The Leukemia & Lymphoma Society - Society : Tools

> Visiting Western New York Chapter | Local links | End Visit

	HOME

PATIENT SERVICES

Call Center

Información - Español

Western New York & Finger Lakes Patient Services

Newly Diagnosed

Find Support

Financial Support

First Connection Request

Stay Informed

Chapter Education Programs

Myelodysplastic Syndromes

Myeloproliferative Disorders

Other Blood Cancers

Childhood Blood Cancers

Treatment & Clinical Trials

National Education Programs

Participate in Events

Partner With Us

Send a Free ePostcard

Volunteer with The Leukemia & Lymphoma Society

e-Store and Special Offers

SCIENCE/PROFESSIONALS

Research Grants

Professional Education

Chapter Professional Education Programs

PubMed

LLS Research & Researchers

Therapy Acceleration Program (TAP)

Email:
Password:

Remember Me
Not Yet Registered?


	Tools

print page

email page

Society News Feeds

Select glossary

Graft Versus Host Disease:

The immune attack by lymphocytes in the donor?s marrow or blood cell suspension (the graft) against the tissues of the recipient (the host). The immune cells most engaged in this reaction are donor T lymphocytes, which are present in the donor?s blood or marrow, the source of stem cells. The principal organs injured are the skin, the liver, and the gastrointestinal tract. The reaction does not occur in identical twin transplants. The reaction may be minimal in closely matched individuals or severe in less well-matched individuals. These reactions are mediated in part by antigens that are not in the HLA system and cannot be matched at this time prior to transplant. These are referred to as minor histocompatibilty antigens. For example, in the case of a female stem cell donor and a male recipient, the female donor?s cells that do not share the genes on the Y chromosome may see factors that are produced by genes on the Y chromosome as foreign. This fact does not prohibit female donors and male recipients, but it makes the risk of immune reaction higher.

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Need Help? Contact us by email, mail, or call (800) 955-4572